Ryan Savitz

Companies

• Magenta TherapeuticsChief financial officer Sep 13, 2023 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MTMagenta Therapeutics DNTH0 shares²Jul 9, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 9, 2026Sold 5,566 shares at $101.97 of Magenta Therapeutics²
• Jul 9, 2026Sold 15,329 shares at $101.24 of Magenta Therapeutics²
• Jul 9, 2026Sold 10,354 shares at $100.22 of Magenta Therapeutics²
• Jul 9, 2026Exercised options 31,249 shares at $21.77 of Magenta Therapeutics²
• Apr 9, 2026Sold 8,224 shares at $89.84 of Magenta Therapeutics³
• Apr 9, 2026Exercised options 8,224 shares at $17.88 of Magenta Therapeutics³
• Mar 31, 2026Sold 7,232 shares at $85.54 of Magenta Therapeutics⁴
• Mar 31, 2026Sold 19,469 shares at $84.57 of Magenta Therapeutics⁴
• Mar 31, 2026Sold 59,800 shares at $83.90 of Magenta Therapeutics⁴
• Mar 31, 2026Sold 2,366 shares at $82.84 of Magenta Therapeutics⁴
• Mar 31, 2026Sold 800 shares at $81.36 of Magenta Therapeutics⁴
• Mar 31, 2026Sold 1,485 shares at $80.25 of Magenta Therapeutics⁴
• Mar 31, 2026Sold 21,825 shares at $78.86 of Magenta Therapeutics⁴
• Mar 31, 2026Sold 1,390 shares at $78.33 of Magenta Therapeutics⁴
• Mar 31, 2026Exercised options 40,000 shares at $17.88 of Magenta Therapeutics⁴
• Mar 31, 2026Exercised options 74,367 shares at $8.44 of Magenta Therapeutics⁴
• Dec 4, 2025Sold 20,000 shares at $45.18 of Magenta Therapeutics⁵
• Dec 4, 2025Exercised options 20,000 shares at $8.44 of Magenta Therapeutics⁵
• Sep 9, 2025Sold 20,000 shares at $35.00 of Magenta Therapeutics⁶
• Sep 9, 2025Exercised options 20,000 shares at $8.44 of Magenta Therapeutics⁶